Erik de Cabo López, M. J. Vidal-Manceñido, Josefina Galende del Canto, Carmen Aguilera Sanz, Marta Megido Lahera, Alicia Smucler Simonovich, Sheila Bodelón Gago, Carlos A. Cuenca Aprell
{"title":"在慢性淋巴细胞白血病中,ibrutinib转换为venetoclax以避免疾病的快速进展:一种基于临床病例的过渡方案","authors":"Erik de Cabo López, M. J. Vidal-Manceñido, Josefina Galende del Canto, Carmen Aguilera Sanz, Marta Megido Lahera, Alicia Smucler Simonovich, Sheila Bodelón Gago, Carlos A. Cuenca Aprell","doi":"10.24875/sangre.m22000005","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":198812,"journal":{"name":"Revista Sangre","volume":"50 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cambio de ibrutinib a venetoclax en la leucemia linfocítica crónica para evitar la progresión rápida de la enfermedad: un protocolo de transición basado en casos clínicos\",\"authors\":\"Erik de Cabo López, M. J. Vidal-Manceñido, Josefina Galende del Canto, Carmen Aguilera Sanz, Marta Megido Lahera, Alicia Smucler Simonovich, Sheila Bodelón Gago, Carlos A. Cuenca Aprell\",\"doi\":\"10.24875/sangre.m22000005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":198812,\"journal\":{\"name\":\"Revista Sangre\",\"volume\":\"50 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-12-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista Sangre\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.24875/sangre.m22000005\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Sangre","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24875/sangre.m22000005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Cambio de ibrutinib a venetoclax en la leucemia linfocítica crónica para evitar la progresión rápida de la enfermedad: un protocolo de transición basado en casos clínicos